Editor's Note The Food and Drug Administration (FDA) on June 8 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit as Class I, the most serious. The HVAD System is used as a bridge to cardiac transplants. The Kit was recalled because of a…
Editor's Note This systematic review and meta-analysis led by researchers in the UK finds that across the world, cardiovascular (CV) services were severely disrupted, and as a result cardiac disease is expected to worsen, and repercussions will be felt for years to come. This analysis spans 2 years (2020 to…
Editor's Note Cardiologists at the University of Washington School of Medicine (UW Medicine) in Seattle, Washington, are participating in a national clinical trial to test a device designed to control bleeding if a vessel near the heart is inadvertently perforated during a catheter-based procedure, Healthcare Purchasing News May 26 reported.…
Editor's Note The Joint Commission and the American Heart Association, on April 20, announced the launch of a Comprehensive Heart Attack Center certification program, which recognizes hospitals providing care to the most complex and critically ill patients. To be certified, hospitals must provide 24-hours-a-day, 7-days-a-week on-site coverage for primary percutaneous…
Ambulatory surgery centers (ASCs) are ramping up cardiovascular and peripheral vascular service lines, as Medicare offers payment for a growing number of cardiac procedures and accrediting bodies offer support for this methodology. In 2021, the Medicare Payment Advisory Commission reported that the number of ASCs billing Medicare for cardiology procedures…
Among Surgical Care Affiliates’ (SCA) 260-plus facilities in the US, at least 10% have added cardiovascular/peripheral vascular service capabilities. SCA experts anticipate more growth in this area. However, any successful launch starts with an organizational focus on patient safety, says Ezra Erb, vice president for clinical quality at SCA, which…
Editor's Note According to the 2022 Key ASC Benchmarks and Industry Figures report published by Avanza Healthcare Strategies, an ASC consulting firm, cardiology is the fastest growing ASC specialty, Becker’s ASC Review March 10 reports. The Avanza report was released on March 8 and is a “compilation of recently [as…
Editor's Note In this study, researchers report the 2-year outcomes for patients enrolled in the Evolut Low Risk Trial (Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients), which show that transcather aortic valve replacement (TAVR) with a supra-annular, self-expanding valve is noninferior to surgical aortic valve replacement (AVR).…
Editor's Note This multi-center, randomized, clinical trial that compares on-pump coronary artery bypass grafting (CABG) with off-pump CABG finds no advantage for off-pump CABG. A total of 2,203 veterans were randomly assigned to off-pump (1,104) or on-pump (1,099) CABG procedures at 18 VA medical centers, and the veterans were then…
Editor's Note The Joint Commission, on February 13, announced that it has partnered with the American Heart Association (AHA) to develop a new advanced disease-specific care certification program for heart attack patient care. The Comprehensive Heart Attack Center (CHAC) Certification Program (CHAC), which is based on AHA clinical practice guidelines…